www.businessinsider.com

www.businessinsider.com
Share

www.businessinsider.com

 •  February 7

Sam Rega / Business Insider Kratom is a drug derived from a plant native to Southeast Asia. On Tuesday, FDA commissioner Scott Gottlieb released a statement officially calling the drug an opioid because of its links to 44 deaths and its molecular structure. Still, there is limited available research on kratom, and the FDA's research is largely...

www.businessinsider.com

 •  January 31

(Reuters) - The U.S. Food and Drug Administration is asking manufacturers of a common opioid medicine to change the way the drug is packaged, as part of efforts to deter its abuse amid an opioid epidemic in the United States. The FDA said on Tuesday it sent letters to manufacturers of diarrhea medicine loperamide, asking them to ensure that...

www.businessinsider.com

 •  January 30

(Reuters) - Corbus Pharmaceuticals Holdings Inc said on Monday the U.S. Food and Drug Administration will evaluate its experimental cystic fibrosis drug without requiring proof the product improves lung function, dramatically cutting the time and cost it will take Corbus to develop the drug. Companies developing drugs for cystic fibrosis, a...

www.businessinsider.com

 •  January 27

Swiss pharmaceutical company Roche newly elected chairman Franz speaks to media after the annual general meeting in Basel Thomson Reuters ZURICH (Reuters) - Fears U.S. President Donald Trump could damage the drugs industry have not been realized and the administration's efforts to accelerate new medicine approvals will bolster the sector, the...

www.businessinsider.com

 •  January 22

Cancer cells are seen on a large screen connected to a microscope at the CeBit computer fair in Hanover, Germany, March, 6, 2012. Reuters Biotech giant Celgene is acquiring Juno Therapeutics for $9 billion. Juno is known for its experimental, highly personalized cancer treatments called CAR T-cell therapy, which harnesses the body's immune system...

www.businessinsider.com

 •  January 20

The FDA approved a "digital pill" that records that the medication was taken. The pill is aimed at treating schizophrenia, manic and mixed episodes associated with bipolar I disorder, and opioid addiction. The main concern with the new medicine is protecting the privacy rights of the patient. In November, the U.S. Food and Drug Administration...

www.businessinsider.com

 •  January 18

By Lisa Rapaport (Reuters Health) - - A pill millions of women have used for morning sickness may not actually help relieve nausea, according to a new study that some doctors say reinforces their decision to stop prescribing the drug. The U.S. Food and Drug Administration (FDA) approved the drug, pyridoxine-doxylamine (Diclegis, Diclectin), based...

www.businessinsider.com

 •  January 16

A nurse reaches for blood samples taken from a patient receiving a kind of immunotherapy known as CAR-T cell therapy at the Fred Hutchinson Cancer Research Center in Seattle. Immune therapy is the hottest trend in cancer care and its next frontier is creating "living drugs" that grow inside the body into an army that seeks and destroys...

www.businessinsider.com

 •  January 12

By Nate Raymond (Reuters) - A former Insys Therapeutics Inc employee accused of engaging in a scheme to pay medical practitioners kickbacks to prescribe a fentanyl-based treatment is seeking to bar U.S. prosecutors from referring to the "opioid crisis" at his trial. Lawyers for Jeffrey Pearlman, a former district sales manager at the drugmaker, in...

www.businessinsider.com

 •  January 6

By Nate Raymond BOSTON (Reuters) - One of the largest patient assistance charities in the United States said it will not provide financial aid in 2018 after the government revoked its approval to do so because of concerns that drugmakers had improper influence over the charity. Caring Voice Coalition's decision prompted the U.S. Department of...